Analystreport

ASLAN PHARMACEU/ADR (NASDAQ: ASLN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

ASLAN Pharmaceuticals Limited - American Depositary Shares  (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com